12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder.
12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder.
To evaluate the efficacy and safety of fesoterodine in comparison to tolterodine and placebo for overactive bladder
Inclusion Criteria:
Exclusion Criteria:
Bonita Spring, Florida 34134, United States
Muelheim A.d. Ruhr, 45468, Germany
Heraklion/Voutes, Crete 71001, Greece
Athens, Maroussi, 14126, Greece
Hyderabad, Andhra Pradesh 500 001, India